CNS Co (4076) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
22 Jul, 2026Executive summary
Revenue for the nine months ended February 2025 increased 4.1% year-over-year to ¥5,186 million, driven by growth in digital transformation and big data analytics projects.
Operating income declined 17.9% year-over-year to ¥420 million due to higher personnel and outsourcing costs, despite reduced advertising expenses.
Net income attributable to shareholders fell 14.5% year-over-year to ¥299 million, impacted by wage increases and changes in cost structure.
Financial highlights
Gross profit rose to ¥1,258 million from ¥1,240 million year-over-year, but operating margin contracted due to increased SG&A expenses.
EPS for the period was ¥103.09, down from ¥120.63 in the prior year.
Total assets stood at ¥4,946 million, with net assets at ¥3,832 million and an equity ratio of 77.5%.
Outlook and guidance
Full-year revenue is forecast at ¥7,562 million, up 13.6% year-over-year, with operating income projected at ¥660 million (+6.6%).
Net income for the full year is expected to reach ¥489 million (+6.2%), with EPS of ¥168.56.
No changes have been made to previously announced guidance.
Latest events from CNS Co
- Double-digit revenue growth driven by DX and consulting, with profit growth to continue.4076
Q4 202422 Jul 2026 - Profit dropped sharply in Q1 FY2025 despite stable revenue, as labor costs surged.4076
Q1 202522 Jul 2026 - Revenue up 2.0% YoY, but profit down on higher costs; full-year outlook maintained.4076
Q2 202522 Jul 2026 - Revenue up 5.2% year-over-year, but profit margins declined amid higher costs and investments.4076
Q4 202522 Jul 2026 - Q1 FY2026 delivered double-digit profit growth, with all segments contributing to higher earnings.4076
Q1 202622 Jul 2026 - Revenue and profits surged on robust DX/AI demand, prompting an upward revision to full-year guidance.4076
Q2 202622 Jul 2026 - Strong revenue and profit growth driven by DX/AI demand, with upwardly revised full-year outlook.4076
Q3 202622 Jul 2026 - Strong revenue and profit growth driven by DX/AI, with double-digit gains and robust FY2027 outlook.4076
Q4 202622 Jul 2026